GMAT Question of the Day - Daily to your Mailbox; hard ones only

It is currently 10 Dec 2019, 10:25

Close

GMAT Club Daily Prep

Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.

Customized
for You

we will pick new questions that match your level based on your Timer History

Track
Your Progress

every week, we’ll send you an estimated GMAT score based on your performance

Practice
Pays

we will pick new questions that match your level based on your Timer History

Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.

Close

Request Expert Reply

Confirm Cancel

A pharmaceutical company developed a new diuretic reported to cause fe

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  
Author Message
TAGS:

Hide Tags

Find Similar Topics 
Math Expert
User avatar
V
Joined: 02 Sep 2009
Posts: 59634
A pharmaceutical company developed a new diuretic reported to cause fe  [#permalink]

Show Tags

New post 10 Oct 2019, 21:28
00:00
A
B
C
D
E

Difficulty:

  15% (low)

Question Stats:

84% (01:42) correct 16% (02:07) wrong based on 83 sessions

HideShow timer Statistics

Competition Mode Question



A pharmaceutical company developed a new diuretic reported to cause fewer side effects than their old diuretic, which was still being manufactured. During the first year that both were sold, the earlier medication far outsold the new one; the manufacturer thus concluded that reducing side effects was not the customers' primary consideration.

Which of the following, if true, would most seriously weaken the manufacturers conclusion?

A. Both hospitals and patients buy diuretics from this pharmaceutical company.
B. Many customers consider older medications a better safety risk than new ones, since more is usually known about the safety of the earlier drugs.
C. Many customers of this pharmaceutical company also bought medications from companies who did not produce new diuretics reported to cause fewer side effects.
D. The newer diuretic can be used by all the patients who could use the earlier diuretic.
E. There was no significant difference in price between the newer diuretic and the earlier diuretic.

_________________
Director
Director
avatar
P
Joined: 18 May 2019
Posts: 539
GMAT ToolKit User Premium Member CAT Tests
Re: A pharmaceutical company developed a new diuretic reported to cause fe  [#permalink]

Show Tags

New post 10 Oct 2019, 22:51
1
The right answer is option B.
If a new diuretic is manufactured by a pharmaceutical company that has fewer side effects than an existing diuretic, the only logical reason why it won't receive higher patronage is if the users are apprehensive about the new drug, since very little information is available about the new drug. It would take some time after the new diuretic has been used by many and proofs of the benefits become well known before it's usage will receive the necessary patronage. This is what option B essentially states, hence it is the best weakener of the conclusion drawn by the argument.

The fact that both hospitals and patients buy medicine from the pharmaceutical company in question is irrelevant. It does not weaken nor strengthen the argument, hence we can discard A.

Option C did not weaken the conclusion made by the argument, but instead it strengthens the argument. We can, therefore, discard C as well.

The fact that the new diuretic can be used by patients who use the old diuretic does not offer any objection or weaken the conclusion made in the argument. D can also be discarded.

The fact that there is no price difference between the old and new diuretic does not provide any objection or weaken the conclusion made in the argument. E can also be discarded.
Senior Manager
Senior Manager
avatar
P
Joined: 22 Feb 2018
Posts: 341
CAT Tests
Re: A pharmaceutical company developed a new diuretic reported to cause fe  [#permalink]

Show Tags

New post 10 Oct 2019, 22:55
1
A pharmaceutical company developed a new diuretic reported to cause fewer side effects than their old diuretic, which was still being manufactured. During the first year that both were sold, the earlier medication far outsold the new one; the manufacturer thus concluded that reducing side effects was not the customers' primary consideration.

Conclusion: The manufacturer thus concluded that reducing side effects was not the customers' primary consideration. It can be weakened by mentioning that reduction of side effect was the only primary consideration of the customers.

Reasoning of the premises may be are as follows,
What if the new diuretic is having too much cost than earlier one.
What if the new diuretic is far more efficient than the old one.
Such consideration weakens the manufacturer's conclusion regarding primary considerations of customers.

Which of the following, if true, would most seriously weaken the manufacturers conclusion?

A. Both hospitals and patients buy diuretics from this pharmaceutical company. - Irrelevant
B. Many customers consider older medications a better safety risk than new ones, since more is usually known about the safety of the earlier drugs. - If new diuretic poses more risk to the safety of the patient than the old one, then many customers opted for the old one rather than new one. Old diuretic is more safer than the new one, indicating the customers are considering safety as the primary reason So, it weakens the conclusion.
C. Many customers of this pharmaceutical company also bought medications from companies who did not produce new diuretics reported to cause fewer side effects.- So what?
D. The newer diuretic can be used by all the patients who could use the earlier diuretic. - so what? irrelevant.
E. There was no significant difference in price between the newer diuretic and the earlier diuretic. - If there no difference in price, then customers could have bought the new one as it's having fewer side effects. But, it's out of context.
_________________
Thanks in the forum can be expressed by hitting KUDOS!!!
GMAT Club Legend
GMAT Club Legend
User avatar
V
Joined: 18 Aug 2017
Posts: 5466
Location: India
Concentration: Sustainability, Marketing
GPA: 4
WE: Marketing (Energy and Utilities)
GMAT ToolKit User Premium Member
Re: A pharmaceutical company developed a new diuretic reported to cause fe  [#permalink]

Show Tags

New post Updated on: 13 Oct 2019, 01:18
1
Premise:During the first year that both were sold, the earlier medication far outsold the new one

conclusion;
the manufacturer thus concluded that reducing side effects was not the customers' primary consideration.

IMO B; weakens the conclusion ; Many customers consider older medications a better safety risk than new ones, since more is usually known about the safety of the earlier drugs.
A pharmaceutical company developed a new diuretic reported to cause fewer side effects than their old diuretic, which was still being manufactured. During the first year that both were sold, the earlier medication far outsold the new one; the manufacturer thus concluded that reducing side effects was not the customers' primary consideration.

Which of the following, if true, would most seriously weaken the manufacturers conclusion?

A. Both hospitals and patients buy diuretics from this pharmaceutical company.
B. Many customers consider older medications a better safety risk than new ones, since more is usually known about the safety of the earlier drugs.
C. Many customers of this pharmaceutical company also bought medications from companies who did not produce new diuretics reported to cause fewer side effects.
D. The newer diuretic can be used by all the patients who could use the earlier diuretic.
E. There was no significant difference in price between the newer diuretic and the earlier diuretic

Originally posted by Archit3110 on 11 Oct 2019, 00:29.
Last edited by Archit3110 on 13 Oct 2019, 01:18, edited 1 time in total.
Manager
Manager
User avatar
G
Joined: 17 Jan 2019
Posts: 127
GMAT ToolKit User Premium Member Reviews Badge
Re: A pharmaceutical company developed a new diuretic reported to cause fe  [#permalink]

Show Tags

New post 11 Oct 2019, 02:09
1
A pharmaceutical company developed a new diuretic reported to cause fewer side effects than their old diuretic, which was still being manufactured. During the first year that both were sold, the earlier medication far outsold the new one; the manufacturer thus concluded that reducing side effects was not the customers' primary consideration.

Which of the following, if true, would most seriously weaken the manufacturers conclusion?

A. Both hospitals and patients buy diuretics from this pharmaceutical company. -- doesn't give any important detail
B. Many customers consider older medications a better safety risk than new ones, since more is usually known about the safety of the earlier drugs. -- the reason customers buy old medication more than new one is they trust in the old brand which is their primary consideration not the result of the sides effects. correct
C. Many customers of this pharmaceutical company also bought medications from companies who did not produce new diuretics reported to cause fewer side effects. -- strenghten
D. The newer diuretic can be used by all the patients who could use the earlier diuretic. -- kinda strenghten
E. There was no significant difference in price between the newer diuretic and the earlier diuretic. --out of scope

therefore, B
Senior Manager
Senior Manager
User avatar
P
Joined: 10 Apr 2018
Posts: 281
Location: India
Concentration: General Management, Operations
GMAT 1: 680 Q48 V34
GPA: 3.3
Premium Member Reviews Badge
Re: A pharmaceutical company developed a new diuretic reported to cause fe  [#permalink]

Show Tags

New post 11 Oct 2019, 02:31
1
Any option that provides an alternate explanation of why older medication outsold the newer one even though newer medication has a clear benefit over the older medication or that reduces our belief in manufacturer's conclusion that reducing side effects was not the customers' primary consideration will weaken the argument.

Option B provides a reason for the difference in sale of the two types of medication, and therefore is the correct answer.

Other options do not impact the argument in the way required.
Director
Director
avatar
P
Joined: 24 Nov 2016
Posts: 935
Location: United States
Re: A pharmaceutical company developed a new diuretic reported to cause fe  [#permalink]

Show Tags

New post 11 Oct 2019, 06:33
1
Quote:
A pharmaceutical company developed a new diuretic reported to cause fewer side effects than their old diuretic, which was still being manufactured. During the first year that both were sold, the earlier medication far outsold the new one; the manufacturer thus concluded that reducing side effects was not the customers' primary consideration.

Which of the following, if true, would most seriously weaken the manufacturers conclusion?

A. Both hospitals and patients buy diuretics from this pharmaceutical company.
B. Many customers consider older medications a better safety risk than new ones, since more is usually known about the safety of the earlier drugs.
C. Many customers of this pharmaceutical company also bought medications from companies who did not produce new diuretics reported to cause fewer side effects.
D. The newer diuretic can be used by all the patients who could use the earlier diuretic.
E. There was no significant difference in price between the newer diuretic and the earlier diuretic.


ARGUMENT
[prem] since old sold more than new, then [con] reducing side effects is not the clients primary consideration;

WEAKEN
A. irev;
C. out of scope;
D. this strengthens;
E. this strengthens;

Answer (B): side effects are primary consideration, thus clients stuck with the old which at the time was perceived to be safer.
Math Expert
User avatar
V
Joined: 02 Sep 2009
Posts: 59634
Re: A pharmaceutical company developed a new diuretic reported to cause fe  [#permalink]

Show Tags

New post 14 Oct 2019, 02:01
Bunuel wrote:

Competition Mode Question



A pharmaceutical company developed a new diuretic reported to cause fewer side effects than their old diuretic, which was still being manufactured. During the first year that both were sold, the earlier medication far outsold the new one; the manufacturer thus concluded that reducing side effects was not the customers' primary consideration.

Which of the following, if true, would most seriously weaken the manufacturers conclusion?

A. Both hospitals and patients buy diuretics from this pharmaceutical company.
B. Many customers consider older medications a better safety risk than new ones, since more is usually known about the safety of the earlier drugs.
C. Many customers of this pharmaceutical company also bought medications from companies who did not produce new diuretics reported to cause fewer side effects.
D. The newer diuretic can be used by all the patients who could use the earlier diuretic.
E. There was no significant difference in price between the newer diuretic and the earlier diuretic.


Official Explanation



Correct Answer: B

The manufactures conclusion was that reducing side effects was not the customers' primary consideration. Choice B states that customers consider older medication a better safety risk, so those customers bought the older diuretic out of safety considerations.
_________________
GMAT Club Bot
Re: A pharmaceutical company developed a new diuretic reported to cause fe   [#permalink] 14 Oct 2019, 02:01
Display posts from previous: Sort by

A pharmaceutical company developed a new diuretic reported to cause fe

  new topic post reply Question banks Downloads My Bookmarks Reviews Important topics  





Powered by phpBB © phpBB Group | Emoji artwork provided by EmojiOne